Michael Powell - Net Worth and Insider Trading
Michael Powell Net Worth
The estimated net worth of Michael Powell is at least $157 Million dollars as of 2024-11-13. Michael Powell is the Director of Seagen Inc and owns about 685,892 shares of Seagen Inc (SGEN) stock worth over $157 Million. Michael Powell is the Director of Ocera Therapeutics Inc and owns about 14,328 shares of Ocera Therapeutics Inc (OCRX) stock worth over $25,647. Michael Powell is also the Director of Molecular Templates Inc and owns about 887 shares of Molecular Templates Inc (MTEM) stock worth over $294. Besides these, Michael Powell also holds Cold Metal Products Inc (CMPI) , Orexigen Therapeutics Inc (OREXQ) . Details can be seen in Michael Powell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Powell has not made any transactions after 2020-08-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Powell
Michael Powell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Powell owns 27 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , Inozyme Pharma Inc (INZY) , and Akouos Inc (AKUS) among others .
Click here to see the complete history of Michael Powell’s form 4 insider trades.
Insider Ownership Summary of Michael Powell
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CMPI | Checkmate Pharmaceuticals Inc | 2020-08-06 | director & 10 percent owner |
INZY | Inozyme Pharma Inc | 2020-07-23 | 10 percent owner |
AKUS | Akouos Inc | 2020-06-25 | 10 percent owner |
2019-11-06 | director & 10 percent owner | ||
2020-01-21 | 10 percent owner | ||
2019-11-15 | 10 percent owner | ||
2017-08-28 | director | ||
2018-09-25 | 10 percent owner | ||
2018-09-18 | 10 percent owner | ||
2016-12-31 | director | ||
2016-10-20 | 10 percent owner | ||
2015-10-06 | 10 percent owner | ||
2015-05-06 | 10 percent owner | ||
2015-01-29 | 10 percent owner | ||
2014-12-02 | 10 percent owner | ||
2014-09-11 | 10 percent owner | ||
2013-10-25 | 10 percent owner | ||
2014-03-20 | 10 percent owner | ||
2012-08-11 | 10 percent owner | ||
2011-12-30 | 10 percent owner | ||
2011-06-02 | director | ||
2011-01-01 | 10 percent owner | ||
2006-03-16 | director & 10 percent owner | ||
2006-05-09 | 10 percent owner | ||
2004-12-16 | director | ||
2021-02-04 | 10 percent owner | ||
2021-05-13 | 10 percent owner |
Michael Powell Latest Holdings Summary
Michael Powell currently owns a total of 5 stocks. Among these stocks, Michael Powell owns 685,892 shares of Seagen Inc (SGEN) as of December 16, 2004, with a value of $157 Million and a weighting of 99.98%. Michael Powell owns 14,328 shares of Ocera Therapeutics Inc (OCRX) as of September 12, 2016, with a value of $25,647 and a weighting of 0.02%. Michael Powell also owns 887 shares of Molecular Templates Inc (MTEM) as of March 16, 2006, with a value of $294 and a weighting of 0%. The other 2 stocks Cold Metal Products Inc (CMPI) , Orexigen Therapeutics Inc (OREXQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Michael Powell
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGEN | Seagen Inc | 2004-12-16 | 685,892 | 228.74 | 156,890,936 |
OCRX | Ocera Therapeutics Inc | 2016-09-12 | 14,328 | 1.79 | 25,647 |
MTEM | Molecular Templates Inc | 2006-03-16 | 887 | 0.33 | 294 |
CMPI | Cold Metal Products Inc | 2020-08-11 | 3,606,707 | 0.00 | 0 |
OREXQ | Orexigen Therapeutics Inc | 2010-12-23 | 0 | 0.01 | 0 |
Holding Weightings of Michael Powell
Michael Powell Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Powell has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the sale of 56,500 shares on December 16, 2004, which brought Michael Powell around $395,500.
According to the SEC Form 4 filings, Michael Powell has made a total of 0 transactions in Ocera Therapeutics Inc (OCRX) over the past 5 years. The most-recent trade in Ocera Therapeutics Inc is the sale of 6,512 shares on September 12, 2016, which brought Michael Powell around $14,913.
According to the SEC Form 4 filings, Michael Powell has made a total of 0 transactions in Molecular Templates Inc (MTEM) over the past 5 years. The most-recent trade in Molecular Templates Inc is the sale of 2,588 shares on March 16, 2006, which brought Michael Powell around $37 Million.
More details on Michael Powell's insider transactions can be found in the Insider Trading History of Michael Powell table.Insider Trading History of Michael Powell
- 1
Michael Powell Trading Performance
GuruFocus tracks the stock performance after each of Michael Powell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Powell is 12.77%. GuruFocus also compares Michael Powell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Powell within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Powell's insider trading performs compared to the benchmark.
Performance of Michael Powell
Michael Powell Ownership Network
Ownership Network List of Michael Powell
Ownership Network Relation of Michael Powell
Michael Powell Owned Company Details
What does Checkmate Pharmaceuticals Inc do?
Who are the key executives at Checkmate Pharmaceuticals Inc?
Michael Powell is the director & 10 percent owner of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .
Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Checkmate Pharmaceuticals Inc Insider Transactions
Michael Powell Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Powell. You might contact Michael Powell via mailing address: 3000 Sand Hill Road, 4-250, Menlo Park Ca 94025.